These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23573472)

  • 1. Prostatic Adenocarcinoma Masquerading as Generalized lymphadenopathy and Mimicking lymphoma on FDG PET/CT: Diagnosis, Staging, and Evaluation of Therapy Response by FDG PET/CT.
    Joshi P; Lele V
    Nephrourol Mon; 2012; 4(2):482-4. PubMed ID: 23573472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography for prostate, bladder, and renal cancer.
    Schöder H; Larson SM
    Semin Nucl Med; 2004 Oct; 34(4):274-92. PubMed ID: 15493005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphadenopathy resulting from acute hepatitis C infection mimicking metastatic breast carcinoma on FDG PET/CT.
    Jacene HA; Stearns V; Wahl RL
    Clin Nucl Med; 2006 Jul; 31(7):379-81. PubMed ID: 16785802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostatic Adenocarcinoma Incognito Manifestation as Generalized Lymphadenopathy: a Rare Case Report.
    Sehrawat A; Gupta S; Alok T
    Indian J Surg Oncol; 2017 Mar; 8(1):91-93. PubMed ID: 28127191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Relevance of Incidental Prostatic Lesions on FDG-Positron Emission Tomography/Computerized Tomography-Should Patients Receive Further Evaluation?
    Reesink DJ; Fransen van de Putte EE; Vegt E; De Jong J; van Werkhoven E; Mertens LS; Bex A; van der Poel HG; van Rhijn BW; Horenblas S; Meijer RP
    J Urol; 2016 Apr; 195(4 Pt 1):907-12. PubMed ID: 26598424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of prostatic adenocarcinoma clinically presenting as supraclavicular and mediastinal lymphadenopathy].
    Tsujino K; Sasada S; Kawahara K; Terada H; Komori C; Suzuki H; Okamoto N; Kobayashi M; Hirashima T; Matsui K; Kawase I
    Nihon Kokyuki Gakkai Zasshi; 2007 Aug; 45(8):648-53. PubMed ID: 17763696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Prostate Cancer Glucose Metabolism Detected by
    Lavallée E; Bergeron M; Buteau FA; Blouin AC; Duchesnay N; Dujardin T; Tiguert R; Lacombe L; Fradet V; Makao-Nguile M; Fradet Y; Beauregard JM; Pouliot F
    Eur Urol Focus; 2019 Nov; 5(6):998-1006. PubMed ID: 29609897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?
    Cuellar SL; Carter BW; Macapinlac HA; Ajani JA; Komaki R; Welsh JW; Lee JH; Swisher SG; Correa AM; Erasmus JJ; Hofstetter WL
    J Thorac Oncol; 2014 Aug; 9(8):1202-6. PubMed ID: 25157774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphadenopathy by Scrub Typhus Mimicking Metastasis on FDG PET/CT in a Patient with a History of Breast Cancer.
    Lee JW; Lee SM; Lee KT; Kim SY; Han SW; Kim SY
    Nucl Med Mol Imaging; 2015 Jun; 49(2):157-9. PubMed ID: 26082810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography/computed tomography hypermetabolism of Kikuchi-Fujimoto disease mimicking malignant lymphoma: a case report and literature review.
    Wang S; Du B; Li X; Li Y
    J Int Med Res; 2021 Jul; 49(7):3000605211032859. PubMed ID: 34334002
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Ram-Wolff C; Vercellino L; Brice P; La Selva R; Bagot M
    Eur J Dermatol; 2017 Oct; 27(5):496-504. PubMed ID: 28721937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follicular Lymphoma mimicking Metastatic Nodes on the F-18 FDG PET/CT and MRI for Staging of Endometrial Cancer.
    Yoon SN
    Nucl Med Mol Imaging; 2018 Apr; 52(2):159-161. PubMed ID: 29662565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Dual-Tracer PET and CT Features to Conventional Risk Categories in Assessing Response to
    Adnan A; Basu S
    J Nucl Med Technol; 2020 Jun; 48(2):148-153. PubMed ID: 32111660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splenic and lymph nodal involvement in sarcoidosis mimicking lymphoma on fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
    Jung RS; Mittal BR; Maturu NV; Bal A; Bhattacharya A; Gupta D
    Indian J Nucl Med; 2015; 30(2):135-8. PubMed ID: 25829731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers.
    Facey K; Bradbury I; Laking G; Payne E
    Health Technol Assess; 2007 Oct; 11(44):iii-iv, xi-267. PubMed ID: 17999839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Value of
    Voskuilen CS; Schweitzer D; Jensen JB; Nielsen AM; Joniau S; Muilwijk T; Necchi A; Azizi M; Spiess PE; Briganti A; Bandini M; Goffin K; Bouchelouche K; van Werkhoven E; Shariat SF; Xylinas E; Azawi NH; Ku JH; Foerster B; van Rhijn BWG; Vegt E; Hendricksen K
    Eur Urol Oncol; 2020 Feb; 3(1):73-79. PubMed ID: 31591037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer.
    Nakagawa M; Hara M; Sakurai K; Ozawa Y; Mizuno A; Tamaki T; Nishio M; Shibamoto Y
    Acta Radiol; 2009 Jul; 50(6):638-44. PubMed ID: 19492198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
    Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
    Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of (18)F-2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography imaging in patients presenting with generalized lymphadenopathy.
    Karunanithi S; Kumar G; Sharma P; Bal C; Kumar R
    Indian J Nucl Med; 2015; 30(1):31-8. PubMed ID: 25589803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.